JL
Jonathan Lim
OtherActivePrincipal at SignalFire
10
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Jonathan Lim.
Investment Thesis & Strategy
SignalFire invests in various stages of SaaS, Consumer Internet, Enterprise Applications, Enterprise Infrastructure, and Mobility companies. As a Principal, Jonathan Lim likely seeks high-growth companies with strong market potential.
Investment Activity
Deals per year over the last 12 years
1
20100
20110
20122
20130
20141
20151
20161
20172
20181
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 10 companies
B
Boundless Bio
Biotech · Series A, 2021
M
Maze Therapeutics
Biotech · Series B, 2019
O
ORIC Pharmaceuticals
Biotech · Series B, 2018
E
Erasca
Biotech · Series B, 2018
B
Black Diamond Therapeutics
Biotech · Series A, 2017
O
OncoMyx Therapeutics
Biotech · Series A, 2016
B
Bonti
Biotech · Series A, 2015
F
Flex Pharma
Biotech · Series A, 2013
I
Ignyta
Biotech · Series A, 2013
I
Independa
Healthcare · Seed, 2010
Frequently Asked Questions
Jonathan Lim focuses on Series B stage investments.
Related Investors
Trevor Oelschig
San Francisco Bay Area, United States · 95 deals
Drew Harman
San Francisco Bay Area, United States · 94 deals
Ben Fletcher
San Francisco Bay Area, United States · 93 deals
Reva Nohria
San Francisco Bay Area, United States · 93 deals
Rajesh Swaminathan
San Francisco Bay Area, United States · 92 deals
Woody Marshall
San Francisco Bay Area, United States · 92 deals